Home › Funds › Casdin Capital › NGNE
Casdin Capital position in NGNE
NEUROGENE INC · Health Care
Latest position (Q2 2026)1.55M sh
Reported value held$48.60M
Portfolio Weight2.43%
First reportedQ4 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 524.62K | $10.17M | New |
| Q1 2024 | 524.62K | $26.70M | Hold |
| Q2 2024 | 524.62K | $19.09M | Hold |
| Q3 2024 | 524.62K | $22.01M | Hold |
| Q4 2024 | 1.30M | $29.61M | Add |
| Q1 2025 | 1.30M | $15.17M | Hold |
| Q2 2025 | 1.30M | $19.37M | Hold |
| Q3 2025 | 1.30M | $22.45M | Hold |
| Q4 2025 | 1.30M | $26.68M | Hold |
| Q1 2026 | 1.42M | $28.63M | Add |
| Q2 2026 | 1.55M | $48.60M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NGNE
- BlackRock Inc 1.06M sh · $33.27M · Q2 2026
- Balyasny Asset Management 818.71K sh · $25.75M · Q2 2026
- Citadel Advisors 435.68K sh · $13.70M · Q2 2026
- Vanguard Group 656.57K sh · $13.53M · Q4 2025
- Fidelity Management & Research (FMR) 295.56K sh · $9.30M · Q2 2026
- Geode Capital Management 293.18K sh · $9.22M · Q2 2026
- Franklin Resources 204.28K sh · $6.42M · Q2 2026
- Morgan Stanley 191.72K sh · $6.03M · Q2 2026
- UBS Group AG 171.29K sh · $5.39M · Q2 2026
- Point72 Asset Management 141.92K sh · $4.46M · Q2 2026
- Moore Capital Management 141.64K sh · $4.45M · Q2 2026